Developing drugs that do not cause tumor regression

MeSH terms

• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / pharmacology*
• Clinical Trials, Phase II as Topic / methods
• Clinical Trials, Phase III as Topic / methods
• Disease Progression
• Double-Blind Method
• Drug Design*
• Humans
• Neoplasms / drug therapy*
• Neoplasms / pathology
• Patient Selection
• Randomized Controlled Trials as Topic / methods*
• Tumor Burden
• United States
• United States Food and Drug Administration
• Withholding Treatment